The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells

Stem Cells and Development

Volumn 22, Issue 20, 2013, Pages 2765-2776

  Bai, Hao ^a   Xie, Yin Liang ^b   Gao, Yong Xing ^a   Cheng, Tao ^b   Wang, Zack Z ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; COLONY FORMING CELL; DOWN REGULATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; MESODERM; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL;

BENZAMIDES; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; COCULTURE TECHNIQUES; DIOXOLES; EMBRYOID BODIES; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LYMPHOCYTE ACTIVATION; MESODERM; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84885159556     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0008     Document Type: Article

References (60)

1. Sabin FR. (1920). Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of induction. Contribut Embryol 9:213-262
2. Wagner RC. (1980). Endothelial cell embryology and growth. Adv Microcirc 9:45-75
3. Pardanaud L, F Yassine and F Dieterlen-Lievre. (1989). Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105:473-485
4. Huber TL, V Kouskoff, HJ Fehling, J Palis and G Keller. (2004). Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432:625-630
5. Yoshimoto M and MC Yoder. (2009). Developmental biology: Birth of the blood cell. Nature 457:801-803
6. Choi K. (1998). Hemangioblast development and regulation. Biochem Cell Biol 76:947-956
7. Kennedy M, SL D'Souza, M Lynch-Kattman, S Schwantz and G Keller. (2007). Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109:2679-2687
8. Kennedy M, M Firpo, K Choi, C Wall, S Robertson, N Kabrun and G Keller. (1997). A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386:488-493
9. Zambidis ET, TS Park, W Yu, A Tam, M Levine, X Yuan, M Pryzhkova and B Peault. (2008). Expression of angiotensinconverting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112:3601-3614
10. Eilken HM, S Nishikawa and T Schroeder. (2009). Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 457:896-900
11. Lancrin C, P Sroczynska, C Stephenson, T Allen, V Kouskoff and G Lacaud. (2009). The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457:892-895
12. Nishikawa SI, S Nishikawa, H Kawamoto, H Yoshida, M Kizumoto, H Kataoka and Y Katsura. (1998). In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity 8:761-769
13. Dzierzak E and NA Speck. (2008). Of lineage and legacy: The development of mammalian hematopoietic stem cells. Nat Immunol 9:129-136
14. Keller G. (2005). Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev 19:1129-1155
15. Onder TT and GQ Daley. (2012). New lessons learned from disease modeling with induced pluripotent stem cells. Curr Opin Genet Dev 22:500-508
16. Wang ZZ, P Au, T Chen, Y Shao, LM Daheron, H Bai, M Arzigian, D Fukumura, RK Jain and DT Scadden. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 25:317-318
17. Bai H, Y Gao, M Arzigian, DM Wojchowski, WS Wu and ZZ Wang. (2010). BMP4 regulates vascular progenitor development in human embryonic stem cells through a smaddependent pathway. J Cell Biochem 109:363-374
18. Massague J. (2012). TGF[beta] signalling in context. Nat Rev Mol Cell Biol 13:616-630
19. Bobik A. (2006). Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26: 1712-1720
20. David L, JJ Feige and S Bailly. (2009). Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20:203-212
21. Goumans MJ, Z Liu and P ten Dijke. (2009). TGF-beta signaling in vascular biology and dysfunction. Cell Res 19: 116-127
22. Massague J and YG Chen. (2000). Controlling TGF-beta signaling. Genes Dev 14:627-644
23. Valdimarsdottir G and C Mummery. (2005). Functions of the TGFbeta superfamily in human embryonic stem cells. APMIS 113:773-789
24. James D, AJ Levine, D Besser and A Hemmati-Brivanlou. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132:1273-1282
25. Vallier L, D Reynolds and RA Pedersen. (2004). Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 275: 403-421
26. Beattie GM, AD Lopez, N Bucay, A Hinton, MT Firpo, CC King and A Hayek. (2005). Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23:489-495
27. Xiao L, X Yuan and SJ Sharkis. (2006). Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24:1476-1486
28. Xu RH, RM Peck, DS Li, X Feng, T Ludwig and JA Thomson. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2:185-190
29. Wang G, H Zhang, Y Zhao, J Li, J Cai, P Wang, S Meng, J Feng, C Miao, et al. (2005). Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 330:934-942
30. Trompouki E, TV Bowman, LN Lawton, ZP Fan, D-C Wu, A DiBiase, CS Martin, JN Cech, AK Sessa, et al. (2011). Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 147:577-589
31. Mullen Alan C, DA Orlando, JJ Newman, J Lovén, RM Kumar, S Bilodeau, J Reddy, MG Guenther, RP DeKoter and RA Young. (2011). Master transcription factors determine cell-type-specific responses to TGF-b signaling. Cell 147:565- 576
32. Zafonte BT, S Liu, M Lynch-Kattman, I Torregroza, L Benvenuto, M Kennedy, G Keller and T Evans. (2007). Smad1 expands the hemangioblast population within a limited developmental window. Blood 109:516-523
33. Liu B, Y Sun, F Jiang, S Zhang, Y Wu, Y Lan, X Yang and N Mao. (2003). Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesis. Blood 101:124-133
34. Zhang L, A Magli, J Catanese, Z Xu, M Kyba and RC Perlingeiro. (2011). Modulation of TGF-beta signaling by endoglin in murine hemangioblast development and primitive hematopoiesis. Blood 118:88-97
35. Perlingeiro RC. (2007). Endoglin is required for hemangioblast and early hematopoietic development. Development 134:3041-3048
36. Wu Z, W Zhang, G Chen, L Cheng, J Liao, N Jia, Y Gao, H Dai, J Yuan and L Xiao. (2008). Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells. J Biol Chem 283:24991-25002
37. Kennedy M, G Awong, CM Sturgeon, A Ditadi, R Lamotte- Mohs, JC Zuniga-Pflucker and G Keller. (2012). T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2:1722-1735
38. Wang X, G Lin, K Martins-Taylor, H Zeng and RH Xu. (2009). Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells. J Biol Chem 284:34054- 34064
39. Chou BK, P Mali, X Huang, Z Ye, SN Dowey, LM Resar, C Zou, YA Zhang, J Tong and L Cheng. (2011). Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21:518-529
40. Kita-Matsuo H, M Barcova, N Prigozhina, N Salomonis, K Wei, JG Jacot, B Nelson, S Spiering, R Haverslag, et al. (2009). Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 4:e5046
41. Bai H, K Chen, Y Gao, M Arzigian, Y Xie, C Malcosky, Y Yang, W Wu and Z Wang. (2012). Bcl-xL enhances singlecell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Res 8:26-37
42. Chen T, H Bai, Y Shao, M Arzigian, V Janzen, E Attar, Y Xie, DT Scadden and ZZ Wang. (2007). SDF-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 25:392-401
43. D'Souza SL, AG Elefanty and G Keller. (2005). SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood 105:3862-3870
44. Watanabe K, M Ueno, D Kamiya, A Nishiyama, M Matsumura, T Wataya, JB Takahashi, S Nishikawa, S Nishikawa, K Muguruma and Y Sasai. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681-686
45. Xu Y, X Zhu, HS Hahm, W Wei, E Hao, A Hayek and S Ding. (2010). Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A 107:8129- 8134
46. Zhang P, J Li, Z Tan, C Wang, T Liu, L Chen, J Yong, W Jiang, X Sun, et al. (2008). Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood 111:1933-1941
47. Yang L, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, et al. (2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524-528
48. Chadwick K, L Wang, L Li, P Menendez, B Murdoch, A Rouleau and M Bhatia. (2003). Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:906-915
49. Laranjeiro R, I Alcobia, H Neves, AC Gomes, P Saavedra, CC Carvalho, A Duarte, A Cidadao and L Parreira. (2012). The notch ligand delta-like 4 regulates multiple stages of early hemato-vascular development. PLoS One 7:e34553
50. Ramirez-Bergeron DL, A Runge, KD Dahl, HJ Fehling, G Keller and MC Simon. (2004). Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 131:4623-4634
51. Mikkola HK, Y Fujiwara, TM Schlaeger, D Traver and SH Orkin. (2003). Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 101:508-516
52. Ferkowicz MJ, M Starr, X Xie, W Li, SA Johnson, WC Shelley, PR Morrison and MC Yoder. (2003). CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 130:4393-4403
53. Amit M, C Shariki, V Margulets and J Itskovitz-Eldor. (2004). Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70:837-845
54. Inman GJ, FJ Nicolas, JF Callahan, JD Harling, LM Gaster, AD Reith, NJ Laping and CS Hill. (2002). SB-431542 is a potent and specific inhibitor of transforming growth factorbeta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62:65-74
55. DaCosta Byfield S, C Major, NJ Laping and AB Roberts. (2004). SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65:744-752
56. Alexandrow MG and HL Moses. (1995). Transforming growth factor beta and cell cycle regulation. Cancer Res 55:1452-1457
57. Cheng T, H Shen, N Rodrigues, S Stier and DT Scadden. (2001). Transforming growth factor beta 1 mediates cellcycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood 98:3643-3649
58. Bratt-Leal AM, RL Carpenedo, MD Ungrin, PW Zandstra and TC McDevitt. (2011). Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. Biomaterials 32:48-56
59. Ran D, WJ Shia, MC Lo, JB Fan, DA Knorr, PI Ferrell, Z Ye, M Yan, L Cheng, DS Kaufman and DE Zhang. (2013). RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood 121:2882-2890
60. Kennedy M, G Awong, CM Sturgeon, A Ditadi, R LaMotte- Mohs, JC Zuniga-Pflucker and G Keller. (2012). T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2:1722-1735